A Mobile Phone Text-based Intervention to Reduce Sedentary Behavior and Engage Communities on the Importance of Healthy Lifestyles: the TEXT2MOVE Study

• Sponsor: M.D. Anderson Cancer Center (Other)
• Overall Status: Recruiting
• CT.gov ID: NCT05217108
• Collaborator: (none)
• Enrollment: 200
• Location: 1
• Arm: 1
• Anticipated Duration (Months): 33.8
• Patients Per Site Per Month: 5.9

Study Details

Study Description

Brief Summary

To learn if an 8-week, phone-based texting intervention program will reduce sedentary (non-mobile) behavior.

Condition or Disease	Intervention/Treatment	Phase
Life Style; Healthy Lifestyle	Device: FitBit	N/A

Detailed Description

Primary Objective: To test the effect of two text messaging strategies, responsive texts and standard scheduled texts, on sedentary behavior in a racially and geographically diverse sample of adults who participate in a community-based MD Anderson educational seminar.

• Primary outcome: Daily minutes in sedentary behavior based on Fitbit data.

Secondary Objective: To assess participant engagement with the program and with the educational content delivered via text messaging.

• Secondary outcomes: To assess participant engagement with text messaging platform

• Clicks on links within texts (clicked link vs. did not click link)

• Compliance to FITBIT syncing (complied vs. did not comply)

• Completion of survey material (completed vs. did not complete)

• Responses to interactive texts (texts that ask questions requesting a response; responded vs. did not respond to text)

Exploratory Objective: To determine whether two text messaging strategies, responsive texts and standard scheduled texts, increases physical activity in a racially and geographically diverse sample of adults who participate in a community-based MD Anderson educational seminar.

• Exploratory Outcome: Daily step count over 8 weeks based on Fitbit data.

Exploratory Objective: To determine whether two text messaging strategies, responsive texts and standard scheduled texts are associated with changes in corresponding patient attitudes as assessed by surveys of exploring sedentary behavior, readiness for exercise change, and physical functioning.

• Exploratory Outcomes: Survey outcomes measured using the SBQ, Stages of Change, and PROMIS surveys.

Study Design

• Study Type: Interventional
• Anticipated Enrollment: 200 participants
• Allocation: N/A
• Intervention Model: Single Group Assignment
• Masking: None (Open Label)
• Primary Purpose: Prevention
• Official Title: A Mobile Phone Text-based Intervention to Reduce Sedentary Behavior and Engage Communities on the Importance of Healthy Lifestyles: the TEXT2MOVE Study
• Actual Study Start Date: Jan 5, 2022
• Anticipated Primary Completion Date: Oct 31, 2024
• Anticipated Study Completion Date: Oct 31, 2024

Arms and Interventions

Arm	Intervention/Treatment
Other: Fit Bit (Study Groups) Participants wear a Fitbit every day for 8 weeks to record the number of steps you take	Device: FitBit; All participants in each study group will receive a Fitbit. Participants will be asked to wear a Fitbit every day for 8 weeks to record the number of steps you take

Outcome Measures

Primary Outcome Measures

1. Daily minutes in sedentary behavior based on Fitbit data. [through study completion, an average of 1 year]

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Inclusion criteria:

1. 18 years old;

2. owns a smart phone;

3. has access to WiFi or willing to use mobile data;

4. has an email address or willing to create an email address;

5. able to read and understand English;

6. able to give informed consent;

7. willing to receive text messages and complete brief questionnaires on their smart phone.

Exclusion criteria:

1. unwilling to have sedentary behavior and activity tracked

2. unable to walk without ambulatory assistance device (i.e. cane or walker) or due to underlying medical condition.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	M D Anderson Cancer Center	Houston	Texas	United States	77030

Sponsors and Collaborators

• M.D. Anderson Cancer Center

Investigators

• Principal Investigator: Karen Basen-Engquist, MD, M.D. Anderson Cancer Center

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

• M D Anderson Cancer Center

Publications

None provided.

• Responsible Party: M.D. Anderson Cancer Center
• ClinicalTrials.gov Identifier: NCT05217108
• Other Study ID Numbers: 2021-1014
• First Posted: Feb 1, 2022
• Last Update Posted: May 31, 2022
• Last Verified: May 1, 2022

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No

Study Results

No Results Posted as of May 31, 2022